GENEVA, Dec. 22 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/055891) for "IMMUNOGENIC COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE" on Jun 09, 2025. With publication no. WO/2025/257712, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERSON, Annaliesa Sybil (c/o Pfizer Inc.401 N. Middletown RoadPearl River, New York 10965), GURTMAN, Alejandra Clarisa (c/o Pfizer Inc.401 N. Middletown RoadPearl Riv...